Seeking Alpha

Henry Schein (HSIC -7.4%) beat Q3 estimates, but earnings climbed less-than-expected as the...

Henry Schein (HSIC -7.4%) beat Q3 estimates, but earnings climbed less-than-expected as the vaccine maker suffered from lower sales of its flu shots and margin pressure due to higher costs. The company also issues cautious guidance for FY12, citing foreign currency concerns.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)